N-Methyl-N-phenethyl-2-phenylethanamine, 95.0%, 250mg

4-Hydrazinyl-1-methyl-1H-pyrazole hydrochloride, 97%, 250mg

2-(4-BROMOPHENYL)CYCLOPROPANAMINE HCL, 95.0%, 100mg

3-Bromo-4-chloro-6-ethoxyquinoline, 95.0%, 1g

(7s,8As)-7-fluorooctahydropyrrolo[1,2-a]pyrazine, 98%, 10g

ethyl 5-bromo-2-ethoxynicotinate, 1g

3-(2-Methoxyphenyl)-1,2-oxazol-5-amine, 97%, 250mg

4-(p-Tolylthio)thieno[2,3-c]pyridine-2-carboxamide>95.0%(HPLC)100mg

Flat flange reaction vial, cylindrical, graduated, with tempering jacket KF connecting piece, DN 100, 1000 ml, 130 mm, 1 Piece

Bis(2-ethylhexyl) cyclohexane-1,2-dicarboxylate, 97.0%, 10g

Methyl 2-hydroxy-1-naphthoate, 95.0%, 10g

(2R,5R)-tert-Butyl 5-(hydroxymethyl)-2-methylpiperazine-1-carboxylate, 95.0%, 5g

4-(4-Benzoylphenoxy)butanoic acid, 98%, 250mg